Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma
出版年份 2015 全文链接
标题
Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma
作者
关键词
-
出版物
Blood Cancer Journal
Volume 5, Issue 3, Pages e296
出版商
Springer Nature
发表日期
2015-03-21
DOI
10.1038/bcj.2015.20
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
- (2014) M A Dimopoulos et al. Blood Cancer Journal
- Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents
- (2013) M. A. Dimopoulos et al. ANNALS OF ONCOLOGY
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- (2013) S K Kumar et al. LEUKEMIA
- Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma
- (2013) A A Chanan-Khan et al. Blood Cancer Journal
- The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma
- (2012) M A Dimopoulos et al. LEUKEMIA
- Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma
- (2012) J T Larsen et al. LEUKEMIA
- The t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies
- (2012) A Kalff et al. Blood Cancer Journal
- Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens
- (2011) Evangelos Eleftherakis-Papapiakovou et al. LEUKEMIA & LYMPHOMA
- The pathogenesis and diagnosis of acute kidney injury in multiple myeloma
- (2011) Colin A. Hutchison et al. Nature Reviews Nephrology
- Diagnosis of Smoldering Multiple Myeloma
- (2011) S. Vincent Rajkumar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM–comorbidity score
- (2011) M Kleber et al. Blood Cancer Journal
- Thalidomide-Dexamethasone as Induction Therapy before Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma and Renal Insufficiency
- (2010) Patrizia Tosi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Immunoglobulin light chains activate nuclear factor- B in renal epithelial cells through a Src-dependent mechanism
- (2010) W.-Z. Ying et al. BLOOD
- The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function
- (2010) Meletios Dimopoulos et al. CANCER
- Back-Calculating Baseline Creatinine with MDRD Misclassifies Acute Kidney Injury in the Intensive Care Unit
- (2010) J. W. Pickering et al. Clinical Journal of the American Society of Nephrology
- Renal function in newly diagnosed multiple myeloma - A demographic study of 1353 patients
- (2010) Lene Meldgaard Knudsen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Meeting the Unmet Needs in Anticoagulant Therapy
- (2010) EUROPEAN JOURNAL OF HAEMATOLOGY
- Light Chain–Induced Acute Renal Failure Can Be Reversed by Bortezomib-Doxorubicin-Dexamethasone in Multiple Myeloma: Results of a Phase II Study
- (2010) Heinz Ludwig et al. JOURNAL OF CLINICAL ONCOLOGY
- Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group
- (2010) Meletios A. Dimopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents
- (2010) Maria Roussou et al. LEUKEMIA RESEARCH
- Evidence for Cytogenetic and Fluorescence In Situ Hybridization Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies
- (2010) Prashant Kapoor et al. MAYO CLINIC PROCEEDINGS
- VMP (Bortezomib, Melphalan, and Prednisone) Is Active and Well Tolerated in Newly Diagnosed Patients With Multiple Myeloma With Moderately Impaired Renal Function, and Results in Reversal of Renal Impairment: Cohort Analysis of the Phase III VISTA Study
- (2009) Meletios A. Dimopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Bortezomib-Induced Survival Signals and Genes in Human Proximal Tubular Cells
- (2008) R. Sarkozi et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma
- (2008) R A Kyle et al. LEUKEMIA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now